GeneDx Holdings (WGS) Change in Inventory (2020 - 2026)

GeneDx Holdings has disclosed Change in Inventory across 7 years of filings, most recently posting -$1.7 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 183.12% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$285000.0 (down 116.38% YoY), while the FY2025 annual figure was $3.4 million, up 32.92% from the prior year.
• Change in Inventory declined to -$1.7 million in Q1 2026, from $3.4 million in the prior quarter.
• Over the last five years, Change in Inventory for WGS reached as high as $3.4 million in Q4 2025 and fell as low as -$7.6 million in Q4 2022.
• The 5-year median for Change in Inventory is -$293000.0 (2023), against an average of $59235.3.
• The widest YoY moves for Change in Inventory: up 640.97% in 2025, down 379.25% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$7.6 million in 2022, then surged by 96.14% to -$293000.0 in 2023, then surged by 254.95% to $454000.0 in 2024, then soared by 640.97% to $3.4 million in 2025, then tumbled by 150.21% to -$1.7 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$1.7 million, $3.4 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.